Back to resultsM-CPP and Fenfluramine in Cocaine Addicts - 3
Primary Purpose
Cocaine-Related Disorders
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
M-CPP
Sponsored by
About this trial
This is an interventional treatment trial for Cocaine-Related Disorders focused on measuring cocaine dependence
Eligibility Criteria
Please contact site for information.
Sites / Locations
- VA Medical Center
Outcomes
Primary Outcome Measures
Drug use
Hospitalization, arrests, jail, employment, psychiataric symptoms
Secondary Outcome Measures
Full Information
NCT ID
NCT00000314
First Posted
September 20, 1999
Last Updated
January 17, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
VA Office of Research and Development
1. Study Identification
Unique Protocol Identification Number
NCT00000314
Brief Title
M-CPP and Fenfluramine in Cocaine Addicts - 3
Official Title
To Study Predictive Values of M-CPP and Fenfluramine in Cocaine Addicts
Study Type
Interventional
2. Study Status
Record Verification Date
December 2002
Overall Recruitment Status
Completed
Study Start Date
September 1994 (undefined)
Primary Completion Date
August 1999 (Actual)
Study Completion Date
August 1999 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
VA Office of Research and Development
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to evaluate predictive value of M-CPP and fenfluramine challenges for outcome.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders
Keywords
cocaine dependence
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Enrollment
0 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
M-CPP
Primary Outcome Measure Information:
Title
Drug use
Title
Hospitalization, arrests, jail, employment, psychiataric symptoms
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laure Buydens-Branchey, M.D.
Organizational Affiliation
VA Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
VA Medical Center
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11209
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
31865308
Citation
Ulmann G, Jouinot A, Tlemsani C, Curis E, Kousignian I, Neveux N, Durand JP, Goldwasser F, Cynober L, De Bandt JP. Lean Body Mass and Endocrine Status But Not Age Are Determinants of Resting Energy Expenditure in Patients with Non-Small Cell Lung Cancer. Ann Nutr Metab. 2019;75(4):223-230. doi: 10.1159/000504874. Epub 2019 Dec 19.
Results Reference
derived
Learn more about this trial
M-CPP and Fenfluramine in Cocaine Addicts - 3
We'll reach out to this number within 24 hrs